Timothy Nj Bullock

29PUBLICATIONS
96CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 11, 2026
Myeloid Cell Targeting Strategies Show Limited Durable Activity in the Breast Cancer Tumor Microenvironment and Do Not Enhance the Activity of Thermally Ablative Focused Ultrasound.

|May 29, 2026
<i>UBA1-CDK16</i>: A female-specific chimeric RNA emerging through evolution and involved in immune regulation.

|Apr 10, 2026
Randomized Phase I/II Clinical Trial of a Melanoma Helper Peptide Vaccine with or without Systemic Agonistic Anti-CD27 Antibody (Varlilumab).

Emily K Ninmer, Gina R Petroni, Elizabeth Gaughan

|Mar 03, 2026
Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC).

Emily K Ninmer, Gina R Petroni, Brian R Gastman

|Feb 10, 2026
The influence of VEGFR-2 blockade and focused ultrasound blood-brain barrier opening on the glioma-immune landscape.

Katherine M Nowak, Matthew R Hoch, Victoria R Breza

|Feb 09, 2026
ST2 Signaling Regulates Innate Immune Responses in Kidney Injury.

Vikram Sabapathy, Gabrielle Costlow, Saanvi Acharya

Pageof 5

Frequent Collaborators

5 joint publications

Craig L Slingluff

5 joint publications

Richard J Price

3 joint publications

Michael G Brown

3 joint publications

Ryan D Gentzler